Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Medbanks Closes $59 Million D Round for China Oncology Database

publication date: Jan 11, 2019

Medbanks Network Technology, a Beijing oncology database company, completed a $59 million Series D funding, led by CLP Fund and CDH Investments. Medbanks is building a China-specific tumor data platform that it considers state-of-the-art. It is aimed at serving clinicians, scientists and pharmas. Established in 2014, the company uses "sky eye hardware" to collect data from multiple China cancer centers, which follow a patient through the whole course of cancer treatment, from diagnosis to follow-up. More details....

Share this with colleagues:

This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

ChinaBio® Events


China Showcase 2020

San Francisco, USA

January 12, 2020

ChinaBio Partnering Forum 2020

Suzhou, China

May 6-7, 2020